HBIMEDICAL ApS: Financial statements 2025
CVR: 36426063
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
HBIMEDICAL ApS (CVR 36426063) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -34,441 and a net result of DKK -34,479 compared with DKK 42,098 the year before. Equity in the 2025 report amounted to DKK 145,118. The solvency ratio was 93.2%.
- Gross Profit
- DKK -34,441
- Profit/Loss
- DKK -34,479
- Equity
- DKK 145,118
- Total Assets
- DKK 155,721
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -34 t. | -34 t. | 145 t. | 0 |
| 2024 | - | 52 t. | 42 t. | 180 t. | 1 |
| 2023 | - | -63 t. | -68 t. | 137 t. | 1 |
| 2022 | - | 39 t. | 36 t. | 205 t. | 1 |
| 2021 | - | 125 t. | 119 t. | 219 t. | 1 |
Official annual report
How creditworthy is HBIMEDICAL ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
HBIMEDICAL ApS has published its annual report for 2024. Gross profit came to DKK 51,713, and the net result was DKK 42,098.
About HBIMEDICAL ApS
HBIMEDICAL ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2014. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Hanne Busch Ibsen. The company is owned by Hanne Busch Ibsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -34,441 and a net result of DKK -34,479 compared with DKK 42,098 the year before. Equity in the 2025 report amounted to DKK 145,118.